Trial · NCT02539225
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part A | STARTED | Ramucirumab + S-1 + Oxaliplatin | 97 | |
| Part A | STARTED | Placebo + S-1 + Oxaliplatin | 94 | |
| Part A | Received Any Quantity of Study Drug | Ramucirumab + S-1 + Oxaliplatin | 96 | |
| Part A | Received Any Quantity of Study Drug | Placebo + S-1 + Oxaliplatin | 93 | |
| Part A | COMPLETED | Ramucirumab + S-1 + Oxaliplatin | 77 | |
| Part A | COMPLETED | Placebo + S-1 + Oxaliplatin | 78 | |
| Part A | NOT COMPLETED | Ramucirumab + S-1 + Oxaliplatin | 20 | |
| Part A | NOT COMPLETED | Placebo + S-1 + Oxaliplatin | 16 | |
| Pre Treatment for Part B | STARTED | Ramucirumab + S-1 + Oxaliplatin | 63 | |
| Pre Treatment for Part B | STARTED | Placebo + S-1 + Oxaliplatin | 66 | |
| Pre Treatment for Part B | COMPLETED | Ramucirumab + S-1 + Oxaliplatin | 58 | |
| Pre Treatment for Part B | COMPLETED | Placebo + S-1 + Oxaliplatin | 64 | |
| Pre Treatment for Part B | NOT COMPLETED | Ramucirumab + S-1 + Oxaliplatin | 5 | |
| Pre Treatment for Part B | NOT COMPLETED | Placebo + S-1 + Oxaliplatin | 2 | |
| Part B | STARTED | Ramucirumab + S-1 + Oxaliplatin | 58 | |
| Part B | STARTED | Placebo + S-1 + Oxaliplatin | 64 | |
| Part B | COMPLETED | Ramucirumab + S-1 + Oxaliplatin | 54 | |
| Part B | COMPLETED | Placebo + S-1 + Oxaliplatin | 48 | |
| Part B | NOT COMPLETED | Ramucirumab + S-1 + Oxaliplatin | 4 | |
| Part B | NOT COMPLETED | Placebo + S-1 + Oxaliplatin | 16 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02539225/flow